DK1042288T3 - Tripeptidyl-peptidase inhibitorer - Google Patents

Tripeptidyl-peptidase inhibitorer

Info

Publication number
DK1042288T3
DK1042288T3 DK98966427T DK98966427T DK1042288T3 DK 1042288 T3 DK1042288 T3 DK 1042288T3 DK 98966427 T DK98966427 T DK 98966427T DK 98966427 T DK98966427 T DK 98966427T DK 1042288 T3 DK1042288 T3 DK 1042288T3
Authority
DK
Denmark
Prior art keywords
tripeptidyl
peptidase inhibitors
compound
peptidase
concerns
Prior art date
Application number
DK98966427T
Other languages
English (en)
Inventor
Froylan Nathan Vargas
Charon Robin Ganellin
Lihua Zhao
Sanjeeda Samad
Yongjun Chen
Christiane Rose
Jean-Charles Schwartz
Original Assignee
Inst Nat Sante Rech Med
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Bioprojet Soc Civ filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1042288T3 publication Critical patent/DK1042288T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98966427T 1997-12-23 1998-12-23 Tripeptidyl-peptidase inhibitorer DK1042288T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97403148 1997-12-23
PCT/EP1998/008558 WO1999033801A1 (en) 1997-12-23 1998-12-23 Tripeptidyl peptidase inhibitors

Publications (1)

Publication Number Publication Date
DK1042288T3 true DK1042288T3 (da) 2008-01-28

Family

ID=8229935

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966427T DK1042288T3 (da) 1997-12-23 1998-12-23 Tripeptidyl-peptidase inhibitorer

Country Status (11)

Country Link
US (1) US6335360B1 (da)
EP (1) EP1042288B1 (da)
JP (1) JP3943332B2 (da)
AT (1) ATE377586T1 (da)
CA (1) CA2315703C (da)
CY (1) CY1107039T1 (da)
DE (1) DE69838686T2 (da)
DK (1) DK1042288T3 (da)
ES (1) ES2297905T3 (da)
PT (1) PT1042288E (da)
WO (1) WO1999033801A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230376B1 (hu) 2000-10-30 2016-03-29 Janssen Pharmaceutica N.V Tripeptidil peptidáz inhibitorok
US6864742B2 (en) * 2001-06-08 2005-03-08 Northrop Grumman Corporation Application of the doherty amplifier as a predistortion circuit for linearizing microwave amplifiers
US20040097422A1 (en) * 2002-06-14 2004-05-20 Karl Munger Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents
EP2160196A2 (en) * 2006-01-13 2010-03-10 Oncoreg AB Compounds for the treatment of ischemia and neurodegeneration
US20100240591A1 (en) * 2007-06-25 2010-09-23 Oncoreg Ab Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
CN110256326B (zh) * 2019-07-16 2022-05-13 辽宁中医药大学 马齿苋中一种二氢吲哚羧酸类生物碱及其提取分离方法与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206757D0 (en) * 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
CA2118985A1 (en) * 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
FR2723739B1 (fr) * 1994-08-19 1997-02-14 Sanofi Sa Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
FR2733995B1 (fr) * 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments

Also Published As

Publication number Publication date
US6335360B1 (en) 2002-01-01
WO1999033801A1 (en) 1999-07-08
ES2297905T3 (es) 2008-05-01
DE69838686D1 (de) 2007-12-20
JP2002535240A (ja) 2002-10-22
CA2315703A1 (en) 1999-07-08
ATE377586T1 (de) 2007-11-15
DE69838686T2 (de) 2008-08-28
JP3943332B2 (ja) 2007-07-11
CY1107039T1 (el) 2012-09-26
EP1042288A1 (en) 2000-10-11
CA2315703C (en) 2008-02-05
PT1042288E (pt) 2008-03-11
EP1042288B1 (en) 2007-11-07

Similar Documents

Publication Publication Date Title
NZ335981A (en) Ketobenzamides as calpain inhibitors
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
BR9805544C1 (pt) Uso de um composto.
AU2001271686A1 (en) Compounds to treat alzheimer's disease
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
MY129409A (en) Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
BR0317715A (pt) Composições e processos de uso de collajolie
DE69816280D1 (de) Inhibitoren des impdh-enzyms
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
SE9703693D0 (sv) Novel combination
EA200201175A1 (ru) Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза
HK1060729A1 (en) Inhibitors of cruzipain and other cysteine proteases
BR9815469A (pt) Inibidores de protease
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
MX9801190A (es) Inhibidores de prolil endopeptidasa.
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
BR0012675A (pt) Uso de inibidores de il-18
GB9626472D0 (en) New use of comt inhibitors
DE69930844D1 (de) Inhibitoren von mycobakterien
SE9800139D0 (sv) New use